Literature DB >> 12428668

Factors regulating collagen synthesis and degradation during second-intention healing of wounds in the thoracic region and the distal aspect of the forelimb of horses.

Anne J Schwartz1, David A Wilson, Kevin G Keegan, Venkataseshu K Ganjam, Yao Sun, Karl T Weber, Jiakun Zhang.   

Abstract

OBJECTIVE: To determine significant molecular and cellular factors responsible for differences in second-intention healing in thoracic and metacarpal wounds of horses. ANIMALS: 6 adult mixed-breed horses. PROCEDURE: A full-thickness skin wound on the metacarpus and another such wound on the pectoral region were created, photographed, and measured, and tissue was harvested from these sites weekly for 4 weeks. Gene expression of type-I collagen, transforming growth factor (TGF)-beta1, matrix metalloproteinase (MMP)-1, and tissue inhibitor of metalloproteinase (TIMP)-1 were determined by quantitative in situ hybridization. Myofibroblasts were detected by immunohistochemical labeling with alpha-smooth muscle actin (alpha-SMA). Collagen accumulation was detected by use of picrosirius red staining. Tissue morphology was examined by use of H&E staining.
RESULTS: Unlike thoracic wounds, forelimb wounds enlarged during the first 2 weeks. Myofibroblasts, detected by week 1, remained abundant with superior organization in thoracic wounds. Type-I collagen mRNA accumulated progressively in both wounds. More type-I collagen and TGF-beta1 mRNA were seen in forelimb wounds. Volume of MMP-1 mRNA decreased from day 0 in both wounds. By week 3, TIMP-1 mRNA concentration was greater in thoracic wounds. CONCLUSIONS AND CLINICAL RELEVANCE: Greater collagen synthesis in metacarpal than thoracic wounds was documented by increased concentrations of myofibroblasts, type-I collagen mRNA,TGF-beta1 mRNA, and decreased collagen degradation (ie, MMP-1). Imbalanced collagen synthesis and degradation likely correlate with development of exuberant granulation tissue, delaying healing in wounds of the distal portions of the limbs. Factors that inhibit collagen synthesis or stimulate collagenase may provide treatment options for horses with exuberant granulation tissue.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12428668     DOI: 10.2460/ajvr.2002.63.1564

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  6 in total

Review 1.  Biopolymers: Applications in wound healing and skin tissue engineering.

Authors:  T G Sahana; P D Rekha
Journal:  Mol Biol Rep       Date:  2018-08-09       Impact factor: 2.316

2.  Endothelial cell hypertrophy is associated with microvascular occlusion in horse wounds.

Authors:  Valérie Dubuc; Elodie Lepault; Christine L Theoret
Journal:  Can J Vet Res       Date:  2006-07       Impact factor: 1.310

3.  The effects of equine peripheral blood stem cells on cutaneous wound healing: a clinical evaluation in four horses.

Authors:  J H Spaas; S Broeckx; G R Van de Walle; M Polettini
Journal:  Clin Exp Dermatol       Date:  2013-04       Impact factor: 3.470

4.  Equine CTNNB1 and PECAM1 nucleotide structure and expression analyses in an experimental model of normal and pathological wound repair.

Authors:  Vincenzo Miragliotta; Zoë Ipiña; Josiane Lefebvre-Lavoie; Jacques G Lussier; Christine L Theoret
Journal:  BMC Physiol       Date:  2008-01-31

5.  Immunohistochemical Expression of Collagens in the Skin of Horses Treated with Leukocyte-Poor Platelet-Rich Plasma.

Authors:  Maria Verônica de Souza; Mariana Brettas Silva; José de Oliveira Pinto; Marianna Barros de Souza Lima; Júlio Crepaldi; Gabriela Francine Martins Lopes; Hélio Batista dos Santos; Rosy Iara Maciel de Azambuja Ribeiro; Ralph Gruppi Thomé
Journal:  Biomed Res Int       Date:  2015-07-07       Impact factor: 3.411

6.  Effect of Allogeneic Oral Mucosa Mesenchymal Stromal Cells on Equine Wound Repair.

Authors:  Paola Di Francesco; Pauline Cajon; Christophe Desterke; Marie-France Perron Lepage; Jean-Jacques Lataillade; Tewfik Kadri; Olivier M Lepage
Journal:  Vet Med Int       Date:  2021-12-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.